About Apnar Pharma Private Limited
Data last updated:
Apnar Pharma Private Limited is a private limited company based in Padra, Gujarat, India, a subsidiary of Apnar Pharma Lp. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U73100GJ2014PTC081520. Its GSTIN is 24AANCA0939J1ZK (Gujarat). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹7.6 Cr and a paid-up capital of ₹7.55 Cr. It was formerly known as Apnar Research Pharma Private Limited. It is led by directors including Umesh Patel and Dharmesh Bhikhabhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Block No. 102 At & Po. Gavasad Padra Jambusar Road, Gujarat, India – 391430.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.22 Cr, a decline of 48% compared to the previous year. For the same year it recorded a net loss of ₹68.65 Lakh (net margin -4.8%) and EBITDA of ₹4.24 Cr (EBITDA margin 29.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 21% over five years.
The company has about 95 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Apnar Pharma. As per MCA filings, the company has open charges of ₹50.35 Cr on record. Court records list 9 cases involving the company, including 9 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website apnarpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressBlock No. 102 At & Po. Gavasad Padra Jambusar Road, Gujarat, India – 391430
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Apnar Pharma Private Limited
Apnar Pharma operates one associated brand: Apnar Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables. | apnarpharma.com |
Competitors & Alternatives of Apnar Pharma Private Limited
Brands and companies operating in the same space as Apnar Pharma Private Limited include Jubilant Life Sciences, Akums, Nectar Lifesciences and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Jubilant Life Sciences | Company offering a suite of R&D and manufacturing services for small molecules and generics | Noida, India | 1978 |
 Akums | CDMO focusing on spectrum of dosage forms and therapeutic segments | Delhi, India | 2004 |
 Nectar Lifesciences | Cephalosporin APIs and generic formulations are manufactured. | Chandigarh, India | 1995 |
 Windlas | Biopharma regulatory affairs, quality control, and strategy services are provided. | Gurugram, India | 2001 |
 Unither | Contract development and manufacturing organization for proprietary and generic drugs | Paris, France | 1993 |
 Recipharm | Pharmaceutical development and manufacturing services are offered contractually. | Jordbro, Sweden | 1995 |
 CoreRx | CDMO with a focus on early phase drug product development | Clearwater, United States | 2006 |
 Aenova Group | CDMO services for pharmaceuticals, medical devices, and nutraceuticals are provided. | Starnberg, Germany | 2008 |
 Zambon Pharma | APIs and finished drugs are developed and manufactured in pharmaceuticals. | Bresso, Italy | 1906 |
 Leukocare | Proprietary stabilizing solutions for biologics formulations are developed. | Munich, Germany | 2003 |
Business Activity of Apnar Pharma Private Limited
The main business activity of Apnar Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Apnar Pharma Private Limited
Apnar Pharma Private Limited is audited by SHAH SANGHVI & ASSOCIATES for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SHAH SANGHVI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Apnar Pharma Private Limited
Apnar Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umesh Patel | Director | 25 Feb 2015 | 11 Years 7 Months | Current |
| Dharmesh Bhikhabhai Patel Also directs: Apken Api Private Limited | Director | 24 Jan 2015 | 11 Years 8 Months | Current |
| Swapnil Kantibhai Patel Also directs: Apken Api Private Limited | Director | 12 Dec 2014 | 11 Years 9 Months | Current |
Financials of Apnar Pharma Private Limited FY 2025 filings available
Apnar Pharma Private Limited reported revenue of ₹14.22 Cr (down 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Apnar Pharma Private Limited
Revenue fell 48% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Apnar Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.24 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹68.65 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Apnar Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -4.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Apnar Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Apnar Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Apnar Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2022 | Others | ₹7.5 Cr | Open |
| 09 Dec 2021 | Others | ₹83.38 Lakh | Open |
| 24 Aug 2020 | Others | ₹1.66 Cr | Open |
| 26 May 2020 | Hdfc Bank Limited | ₹19.87 Cr | Open |
| 16 Dec 2017 | Others | ₹11.49 Cr | Open |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Apnar Pharma Private Limited
Apnar Pharma Private Limited has a workforce of 95 employees as of Feb 27, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Apnar Pharma Private Limited
Apnar Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AANCA0939J1ZK | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Apnar Pharma Private Limited
Apnar Pharma Private Limited has 9 court cases on record: 9 filed against it. All cases are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 9 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (COMMS) | Filed against the company by Shriji Polymers (India) Limited | Disposed |
| District court, South West, Delhi | Civil suit | Filed against the company by Mechmaark Filtech India Private Limited | Disposed |
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by Aditya Birla Capital Limited | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Government Labour Officer T.J.Pandya | Disposed |
| District court, Vadodara, Gujarat | Court case (CR EN) | Filed against the company by Government Labour Officer T.J.Pandya | Disposed |
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Apnar Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Apnar Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Apnar Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Apnar Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Apnar Pharma Private Limited
Frequently Asked Questions about Apnar Pharma Private Limited
Apnar Pharma is an active private limited company based in Padra, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2014 (12+ years old) and is registered under CIN U73100GJ2014PTC081520.
Apnar Pharma reported revenue of ₹14.22 Cr for FY 2025 (down 48% YoY).
Apnar Pharma has 3 current directors:
- Umesh Patel - Director
- Dharmesh Bhikhabhai Patel - Director
- Swapnil Kantibhai Patel - Director
Apnar Pharma reported a net loss of ₹68.65 Lakh (net margin -4.8%) and EBITDA of ₹4.24 Cr (EBITDA margin 29.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Apnar Pharma is -2% over three years and 21% over five years. In the latest year (FY 2025) revenue fell 48%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Apnar Pharma is 24AANCA0939J1ZK, registered in Gujarat. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Apnar Pharma is U73100GJ2014PTC081520. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apnar Pharma has 9 court cases on record: 9 filed against it.
Apnar Pharma was incorporated on 12 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.